STOCK TITAN

[SCHEDULE 13G] USANA HEALTH SCIENCES INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Dimensional Fund Advisors LP reports holding 915,049 shares of USANA Health Sciences Inc common stock, representing 5.0% of the class. The filing states that the reported shares are owned by investment funds advised or sub‑advised by Dimensional, which disclaims beneficial ownership and says the holdings are managed in the ordinary course of business and not for the purpose of changing or influencing control. Of the reported shares, Dimensional asserts sole voting power over 887,817 shares and sole dispositive power over 915,049 shares; no shared voting or dispositive power is reported.

The statement clarifies these holdings arise from Dimensional’s advisory roles to registered investment companies, commingled funds, group trusts and separate accounts and that no single Fund listed is known to hold more than 5% of the class. The filing includes the required certification by Dimensional’s compliance officer.

Dimensional Fund Advisors LP riferisce di detenere 915.049 azioni ordinarie di USANA Health Sciences Inc, che rappresentano 5.0% della classe. L'atto di deposito indica che le azioni riportate sono possedute da fondi d'investimento consigliati o sub-consigliati da Dimensional, che rinuncia alla proprietà benefica e afferma che le partecipazioni sono gestite nell'ordinario corso aziendale e non per lo scopo di modificare o influire sul controllo. Delle azioni riportate, Dimensional sostiene potere di voto esclusivo su 887.817 azioni e potere dispositivo esclusivo su 915.049 azioni; nessun potere di voto o dispositiva condiviso è riportato.

La dichiarazione chiarisce che tali partecipazioni derivano dai ruoli di advisory di Dimensional verso fondi comuni di investimento registrati, fondi commingled, group trusts e conti separati e che nessun fondo elencato possiede più del 5% della classe. Il deposito include la certificazione richiesta dall'ufficio di conformità di Dimensional.

Dimensional Fund Advisors LP informa poseer 915,049 acciones de USANA Health Sciences Inc, representando 5.0% de la clase. El informe establece que las acciones reportadas son propiedad de fondos de inversión asesorados o subasesorados por Dimensional, que niega la titularidad beneficiosa y dice que las participaciones se gestionan en el curso normal de negocio y no con el fin de cambiar o influir sobre el control. De las acciones reportadas, Dimensional afirma poder de voto exclusivo sobre 887,817 acciones y poder dispositivo exclusivo sobre 915,049; no se reporta poder de voto o dispositiva compartido.

La declaración aclara que estas participaciones provienen de las funciones de asesoría de Dimensional a compañías de inversión registradas, fondos comund_embd, group trusts y cuentas separadas y que ningún Fondo listado posee más del 5% de la clase. El informe incluye la certificación requerida por el oficial de cumplimiento de Dimensional.

Dimensional Fund Advisors LP는 USANA Health Sciences Inc 일반 주식 915,049주를 보유하고 있으며, 이는 클래스의 5.0%에 해당합니다. 공시에는 보고된 주식이 Dimensional이 자문하거나 하부 자문하는 투자펀드에 의해 소유되며, 유익한 소유권을 부인하고 보유가 일반적 영업 과정에서 관리되며 지배구조를 변경하거나 영향을 주기 위한 목적이 아니라고 명시되어 있습니다. 보고된 주식 중 Dimensional은 단독 의결권이 887,817주, 단독 처분권이 915,049주에 대해 있다고 주장합니다; 공동 의결권이나 처분권은 보고되지 않습니다.

성명은 이러한 보유가 Dimensional의 자문 역할에 따른 것으로 등록 투자회사, 혼합 펀드, 그룹 트러스트 및 분리 계좌에 기인하며, 나열된 단일 펀드가 클래스의 5% 이상을 보유하는 것으로 알려진 바가 없다고 설명합니다. 공시는 Dimensional의 규정 준수 책임자의 필수 인증서를 포함합니다.

Dimensional Fund Advisors LP déclare détenir 915 049 actions ordinaires de USANA Health Sciences Inc, représentant 5.0% de la catégorie. Le dépôt indique que les actions déclarées appartiennent à des fonds d'investissement conseillés ou sub-advisés par Dimensional, qui déclare ne pas détenir de droits de propriété bénéfiques et affirme que les avoirs sont gérés dans le cours normal des activités et non dans le but de changer ou d'influencer le contrôle. Pour les actions déclarées, Dimensional affirme un pouvoir de vote exclusif sur 887 817 actions et un pouvoir dispositif exclusif sur 915 049 actions; aucun pouvoir de vote ou dispositif partagé n'est déclaré.

La déclaration précise que ces avoirs proviennent des activités de conseil de Dimensional auprès de sociétés d'investissement enregistrées, de fonds commingled, de group trusts et de comptes séparés et qu'aucun fonds répertorié ne détient plus de 5% de la catégorie. Le dépôt comprend la certification requise par le responsable de la conformité de Dimensional.

Dimensional Fund Advisors LP meldet holding 915.049 Aktien von USANA Health Sciences Inc. Stammaktien, was 5,0% der Klasse entspricht. Die Einreichung erklärt, dass die gemeldeten Aktien im Eigentum von Investmentfonds stehen, die von Dimensional beraten oder subberatend verwaltet werden, die kein wünschenswertes wirtschaftliches Eigentum beanspruchen und die Beteiligungen im normalen Geschäftsverlauf verwaltet werden und nicht zum Zweck der Veränderung oder Beeinflussung der Kontrolle. Von den gemeldeten Aktien erklärt Dimensional einzelne Stimmrechtsbefugnis über 887.817 Aktien und einzelne dispositive Gewalt über 915.049 Aktien; kein gemeinsames Stimm- oder dispositives Recht wird gemeldet.

Die Erklärung klärt, dass diese Beteiligungen aus Dimensionals Beratungstätigkeit gegenüber registrierten Investmentgesellschaften, commingled funds, Group Trusts und Separater Accounts stammen und kein einzelner Fonds, der aufgeführt ist, mehr als 5% der Klasse hält. Die Einreichung enthält die erforderliche Bestätigung durch Dimensionals Compliance-Beauftragten.

Dimensional Fund Advisors LP يُبلغ عن امتلاكه 915,049 سهمًا من أسهم USANA Health Sciences Inc العادية، ما يمثل 5.0% من الفئة. يوضح التقرير أن الأسهم المبلّغ عنها مملوكة من قبل صناديق استثمارية مُرشدة أو مُشرفة من Dimensional، التي تنفي الملكية المفيدة وتقول أن الحيازات تُدار في مجرى العمل العادي وليست لغرض تغيير أو التأثير في التحكم. من بين الأسهم المبلّغ عنها، تدّعي Dimensional سلطة تصويت حصرية على 887,817 سهمًا و سلطة تصرف حصرية على 915,049 سهمًا؛ لا توجد سلطة تصويت مشتركة أو تصرف مشترَك مُبلغ عنها.

يوضح البيان أن هذه الحيازات ناتجة عن أدوار Dimensional الاستشارية لدى شركات استثمارية مُسجلة وصناديق مدمجة ومواثيق جماعية وحسابات منفصلة، وأنه لا يعرف أي صندوق مُدرج يمتلك أكثر من 5% من الفئة. يتضمن Filing التصديق المطلوب من مسؤول الامتثال في Dimensional.

Dimensional Fund Advisors LP 报告持有 USANA Health Sciences Inc普通股股票915,049股,约占该类别的 5.0% 文件显示,所报股权由Dimensional管理或子咨询的投资基金所拥有,否认受益所有权,并表示持有在正常经营过程中进行管理,而非改变或影响控制权的目的。在所报股中,Dimensional 声称对887,817股拥有单独表决权,对915,049股拥有单独处置权;未报告有共同表决权或共同处置权。

声明澄清这些持股源于Dimensional对注册投资公司、混合基金、集团信托和分离账户的顾问角色,且列示的任何单一基金都未被知悉持有超过该类别的5%。该 filing 包含 Dimensional 合规官员所要求的认证。

Positive
  • Aggregated position of 915,049 shares confirms meaningful institutional interest in USNA
  • Clear disclosure of voting and dispositive powers: 887,817 sole voting; 915,049 sole dispositive
  • Funds own the securities and Dimensional formally disclaims beneficial ownership, clarifying legal ownership and manager role
Negative
  • None.

Insights

Passive adviser holdings at the 5% threshold highlight standard index/quant exposure, not control intent.

The filing shows an aggregated position of 915,049 shares, equal to 5.0% of the class, held across funds for which Dimensional provides advisory services. The statement that the securities are "owned by the Funds" and that Dimensional "disclaims beneficial ownership" is consistent with asset managers reporting aggregated positions while attributing underlying legal ownership to client vehicles.

Key dependencies are the composition of the underlying Funds and their investment mandates; because the filing asserts the position is held in the ordinary course and not to influence control, near‑term governance actions are unlikely. Monitor any future amendments that would show increased voting coordination or a rise above the 5.0% threshold.

Voting and dispositive powers are concentrated within Dimensional’s advisory role, reflecting portfolio-level decision authority.

The schedule reports sole voting power over 887,817 shares and sole dispositive power over 915,049 shares, with no shared powers disclosed. That pattern aligns with a manager executing trading and proxy instructions for client accounts rather than a single beneficial owner directing strategy.

Practical items to watch include any subsequent filings showing changes in the number of shares, voting power breakdowns, or a shift from passive to active intent; such changes would be material to investors and could alter stewardship expectations.

Dimensional Fund Advisors LP riferisce di detenere 915.049 azioni ordinarie di USANA Health Sciences Inc, che rappresentano 5.0% della classe. L'atto di deposito indica che le azioni riportate sono possedute da fondi d'investimento consigliati o sub-consigliati da Dimensional, che rinuncia alla proprietà benefica e afferma che le partecipazioni sono gestite nell'ordinario corso aziendale e non per lo scopo di modificare o influire sul controllo. Delle azioni riportate, Dimensional sostiene potere di voto esclusivo su 887.817 azioni e potere dispositivo esclusivo su 915.049 azioni; nessun potere di voto o dispositiva condiviso è riportato.

La dichiarazione chiarisce che tali partecipazioni derivano dai ruoli di advisory di Dimensional verso fondi comuni di investimento registrati, fondi commingled, group trusts e conti separati e che nessun fondo elencato possiede più del 5% della classe. Il deposito include la certificazione richiesta dall'ufficio di conformità di Dimensional.

Dimensional Fund Advisors LP informa poseer 915,049 acciones de USANA Health Sciences Inc, representando 5.0% de la clase. El informe establece que las acciones reportadas son propiedad de fondos de inversión asesorados o subasesorados por Dimensional, que niega la titularidad beneficiosa y dice que las participaciones se gestionan en el curso normal de negocio y no con el fin de cambiar o influir sobre el control. De las acciones reportadas, Dimensional afirma poder de voto exclusivo sobre 887,817 acciones y poder dispositivo exclusivo sobre 915,049; no se reporta poder de voto o dispositiva compartido.

La declaración aclara que estas participaciones provienen de las funciones de asesoría de Dimensional a compañías de inversión registradas, fondos comund_embd, group trusts y cuentas separadas y que ningún Fondo listado posee más del 5% de la clase. El informe incluye la certificación requerida por el oficial de cumplimiento de Dimensional.

Dimensional Fund Advisors LP는 USANA Health Sciences Inc 일반 주식 915,049주를 보유하고 있으며, 이는 클래스의 5.0%에 해당합니다. 공시에는 보고된 주식이 Dimensional이 자문하거나 하부 자문하는 투자펀드에 의해 소유되며, 유익한 소유권을 부인하고 보유가 일반적 영업 과정에서 관리되며 지배구조를 변경하거나 영향을 주기 위한 목적이 아니라고 명시되어 있습니다. 보고된 주식 중 Dimensional은 단독 의결권이 887,817주, 단독 처분권이 915,049주에 대해 있다고 주장합니다; 공동 의결권이나 처분권은 보고되지 않습니다.

성명은 이러한 보유가 Dimensional의 자문 역할에 따른 것으로 등록 투자회사, 혼합 펀드, 그룹 트러스트 및 분리 계좌에 기인하며, 나열된 단일 펀드가 클래스의 5% 이상을 보유하는 것으로 알려진 바가 없다고 설명합니다. 공시는 Dimensional의 규정 준수 책임자의 필수 인증서를 포함합니다.

Dimensional Fund Advisors LP déclare détenir 915 049 actions ordinaires de USANA Health Sciences Inc, représentant 5.0% de la catégorie. Le dépôt indique que les actions déclarées appartiennent à des fonds d'investissement conseillés ou sub-advisés par Dimensional, qui déclare ne pas détenir de droits de propriété bénéfiques et affirme que les avoirs sont gérés dans le cours normal des activités et non dans le but de changer ou d'influencer le contrôle. Pour les actions déclarées, Dimensional affirme un pouvoir de vote exclusif sur 887 817 actions et un pouvoir dispositif exclusif sur 915 049 actions; aucun pouvoir de vote ou dispositif partagé n'est déclaré.

La déclaration précise que ces avoirs proviennent des activités de conseil de Dimensional auprès de sociétés d'investissement enregistrées, de fonds commingled, de group trusts et de comptes séparés et qu'aucun fonds répertorié ne détient plus de 5% de la catégorie. Le dépôt comprend la certification requise par le responsable de la conformité de Dimensional.

Dimensional Fund Advisors LP meldet holding 915.049 Aktien von USANA Health Sciences Inc. Stammaktien, was 5,0% der Klasse entspricht. Die Einreichung erklärt, dass die gemeldeten Aktien im Eigentum von Investmentfonds stehen, die von Dimensional beraten oder subberatend verwaltet werden, die kein wünschenswertes wirtschaftliches Eigentum beanspruchen und die Beteiligungen im normalen Geschäftsverlauf verwaltet werden und nicht zum Zweck der Veränderung oder Beeinflussung der Kontrolle. Von den gemeldeten Aktien erklärt Dimensional einzelne Stimmrechtsbefugnis über 887.817 Aktien und einzelne dispositive Gewalt über 915.049 Aktien; kein gemeinsames Stimm- oder dispositives Recht wird gemeldet.

Die Erklärung klärt, dass diese Beteiligungen aus Dimensionals Beratungstätigkeit gegenüber registrierten Investmentgesellschaften, commingled funds, Group Trusts und Separater Accounts stammen und kein einzelner Fonds, der aufgeführt ist, mehr als 5% der Klasse hält. Die Einreichung enthält die erforderliche Bestätigung durch Dimensionals Compliance-Beauftragten.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Dimensional Fund Advisors LP
Signature:Selwyn Notelovitz
Name/Title:Global Chief Compliance Officer
Date:10/09/2025

FAQ

What stake in USNA does Dimensional Fund Advisors LP report?

Dimensional reports an aggregate position of 915,049 shares, equal to 5.0% of the class.

Does Dimensional claim beneficial ownership of the reported USNA shares?

No. The filing states the shares are owned by funds advised or sub‑advised by Dimensional and that Dimensional disclaims beneficial ownership.

How much voting power does Dimensional report for USNA shares?

Dimensional reports sole voting power over 887,817 shares and no shared voting power.

Are the holdings intended to influence control of USANA?

The certification states the securities are held in the ordinary course of business and were not acquired to change or influence control.

Who signed the Schedule 13G for Dimensional?

The filing is signed by the Global Chief Compliance Officer, indicating an internal compliance certification of the disclosure.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

484.39M
10.41M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY